WO2001032871A3 - Follistatin-related protein zfsta4 - Google Patents
Follistatin-related protein zfsta4 Download PDFInfo
- Publication number
- WO2001032871A3 WO2001032871A3 PCT/US2000/030013 US0030013W WO0132871A3 WO 2001032871 A3 WO2001032871 A3 WO 2001032871A3 US 0030013 W US0030013 W US 0030013W WO 0132871 A3 WO0132871 A3 WO 0132871A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zfsta4
- follistatin
- related protein
- polypeptides
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002389956A CA2389956A1 (en) | 1999-11-03 | 2000-10-31 | Follistatin-related protein zfsta4 |
JP2001535553A JP2003527099A (en) | 1999-11-03 | 2000-10-31 | Follistatin-related protein ZFSTA4 |
EP00975521A EP1226249A2 (en) | 1999-11-03 | 2000-10-31 | Follistatin-related protein zfsta4 |
AU13564/01A AU1356401A (en) | 1999-11-03 | 2000-10-31 | Follistatin-related protein zfsta4 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43235999A | 1999-11-03 | 1999-11-03 | |
US09/432,359 | 1999-11-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001032871A2 WO2001032871A2 (en) | 2001-05-10 |
WO2001032871A3 true WO2001032871A3 (en) | 2002-02-21 |
Family
ID=23715814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/030013 WO2001032871A2 (en) | 1999-11-03 | 2000-10-31 | Follistatin-related protein zfsta4 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1226249A2 (en) |
JP (1) | JP2003527099A (en) |
AU (1) | AU1356401A (en) |
CA (1) | CA2389956A1 (en) |
WO (1) | WO2001032871A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050075283A1 (en) * | 2001-07-13 | 2005-04-07 | Applera Corporation | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
KR20040096592A (en) * | 2002-02-21 | 2004-11-16 | 와이어쓰 | Follistatin domain containing proteins |
JP4688483B2 (en) * | 2004-04-15 | 2011-05-25 | 株式会社テクノネットワーク四国 | Follistatin variant polypeptide |
US20050287559A1 (en) * | 2004-05-07 | 2005-12-29 | Applera Corporation | Genetic polymorphisms associated with vascular, methods of detection and uses thereof |
WO2008002663A2 (en) | 2006-06-28 | 2008-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | Immunogenic protein constructs |
US20100063258A1 (en) * | 2006-06-28 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion protein constructs |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054358A1 (en) * | 1997-05-26 | 1998-12-03 | Monash University | A method of diagnosing abnormal cell growth |
WO1999025371A1 (en) * | 1997-11-17 | 1999-05-27 | Millennium Pharmaceuticals, Inc. | Novel molecules of the follistatin-related protein family and uses therefor |
WO2000061754A2 (en) * | 1999-04-09 | 2000-10-19 | Curagen Corporation | Human proteins and polynucleotides encoding them |
-
2000
- 2000-10-31 JP JP2001535553A patent/JP2003527099A/en active Pending
- 2000-10-31 EP EP00975521A patent/EP1226249A2/en not_active Withdrawn
- 2000-10-31 WO PCT/US2000/030013 patent/WO2001032871A2/en not_active Application Discontinuation
- 2000-10-31 AU AU13564/01A patent/AU1356401A/en not_active Abandoned
- 2000-10-31 CA CA002389956A patent/CA2389956A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054358A1 (en) * | 1997-05-26 | 1998-12-03 | Monash University | A method of diagnosing abnormal cell growth |
WO1999025371A1 (en) * | 1997-11-17 | 1999-05-27 | Millennium Pharmaceuticals, Inc. | Novel molecules of the follistatin-related protein family and uses therefor |
WO2000061754A2 (en) * | 1999-04-09 | 2000-10-19 | Curagen Corporation | Human proteins and polynucleotides encoding them |
Non-Patent Citations (7)
Title |
---|
DATABASE EM_HTG EMBL; 17 September 1999 (1999-09-17), DOE JOINT GENOME INSTITUTE: "Homo sapiens chromosome 5 clone CTB-49A3, WORKING DRAFT SEQUENCE, 53 unordered pieces.", XP002172088 * |
DATABASE EM_HTG EMBL; 4 August 1999 (1999-08-04), DOE JOINT GENOME INSTITUTE: "Homo sapiens chromosome 5 clone CTC-439D5, WORKING DRAFT SEQUENCE, 19 unordered pieces.", XP002172087 * |
DATABASE EM_HUM EMBL; 30 June 1998 (1998-06-30), KIMMERLY W ET AL.: "Homo sapiens chromosome 5, P1 clone 1265G12 (LBNL H58), complete sequence.", XP002172086 * |
DATABASE EM_HUM EMBL; 4 August 1999 (1999-08-04), OHARA O ET AL.: "Homo sapiens mRNA for KIAA1061 protein, partial cds.", XP002172085 * |
KIKUNO R ET AL.: "Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which encod for large proteins in vitro", DNA RESEARCH, vol. 6, no. 3, 30 June 1999 (1999-06-30), pages 197 - 205, XP000852618 * |
TANAKA M ET AL.: "Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases", INTERNATIONAL IMMUNOLOGY, vol. 10, no. 9, 1998, pages 1305 - 1314, XP000945149, ISSN: 0953-8178 * |
ZWIJSEN A ET AL.: "Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP);cloning and sequencing of the human homologue", EUROPEAN JOURNAL OF BIOCHEMISTRYEUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 225, no. 3, November 1994 (1994-11-01), pages 937 - 946, XP002103181, ISSN: 0014-2956 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001032871A2 (en) | 2001-05-10 |
JP2003527099A (en) | 2003-09-16 |
EP1226249A2 (en) | 2002-07-31 |
AU1356401A (en) | 2001-05-14 |
CA2389956A1 (en) | 2001-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1482040A3 (en) | Nl3 tie receptor tyrosine kinase ligand homologues | |
EP0832973A3 (en) | GTP-binding protein | |
CA2200423A1 (en) | Novel estrogen receptor | |
IE901696L (en) | Fibronectin binding protein as well as its preparation | |
WO1999015653A3 (en) | Tie ligand homologues | |
EP1676857A3 (en) | Receptor that binds trail | |
WO1999020756A3 (en) | Human toll homologues | |
EP1903112A3 (en) | Activin receptors-like kinase(alk), belonging to the TGF receptor family and/or to the BMP receptor family | |
CA2135208A1 (en) | Immunoglobulin binding proteins derived from l protein and their uses | |
CA2302147A1 (en) | Methods for protein screening | |
WO2001032871A3 (en) | Follistatin-related protein zfsta4 | |
PT1009817E (en) | Rtd receptor | |
EP0832978A3 (en) | Novel 3-dehydroquinate synthase | |
WO1997044451A3 (en) | Vasoactive amine binding molecules | |
WO2002055547A3 (en) | Sfrp and peptide motifs that interact with sfrp and methods of their use | |
WO2004090103A8 (en) | Identification of novel nogo-receptors and methods related thereto | |
EP0897011A3 (en) | Novel arginine deiminase | |
EP0801132A3 (en) | Staphylococcal FtsH protein | |
EP0892059A3 (en) | Histidine kinase polypeptides | |
EP0885965A3 (en) | Histidine kinase polypeptides | |
EP0909820A3 (en) | Histidine kinase from Staphylococcus pneumoniae | |
EP0900845A3 (en) | Signal recognition particle polypeptides and polynucleotides | |
EP0885966A3 (en) | Novel compouds | |
EP0900844A3 (en) | Membrane protein of Staphylococcus aureus | |
WO1998027116A3 (en) | Protein binding fragments of gravin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2389956 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000975521 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 535553 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000975521 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000975521 Country of ref document: EP |